Shopping Cart 0
Cart Subtotal
AED 0

Global Prostate Cancer Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 12772

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 19157

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 25543
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Prostate cancer is cancer that occurs in the prostate.

Scope of the Report:

This report studies the Prostate Cancer market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Prostate Cancer market by product type and applications/end industries.

The global Prostate Cancer market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Prostate Cancer.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Astellas, Inc.

AstraZeneca plc

Johnson & Johnson

Sanofi S.A

Bristol Myers Squibb (BMS)

Bayer AG

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Hormone sensitive prostate cancer

Hormone refractory prostate cancer

Market Segment by Applications, can be divided into

Chemotherapy

Hormonal Therapy

Targeted Therapy

Immunotherapy

READ MORE

Table Of Content

Scope

Table of Contents

1 Prostate Cancer Market Overview

1.1 Product Overview and Scope of Prostate Cancer

1.2 Classification of Prostate Cancer by Types

1.2.1 Global Prostate Cancer Revenue Comparison by Types (2017-2023)

1.2.2 Global Prostate Cancer Revenue Market Share by Types in 2017

1.2.3 Hormone sensitive prostate cancer

1.2.4 Hormone refractory prostate cancer

1.3 Global Prostate Cancer Market by Application

1.3.1 Global Prostate Cancer Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Chemotherapy

1.3.3 Hormonal Therapy

1.3.4 Targeted Therapy

1.3.5 Immunotherapy

1.4 Global Prostate Cancer Market by Regions

1.4.1 Global Prostate Cancer Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Prostate Cancer Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Prostate Cancer Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Prostate Cancer Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Prostate Cancer Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Prostate Cancer Status and Prospect (2013-2023)

1.5 Global Market Size of Prostate Cancer (2013-2023)

2 Manufacturers Profiles

2.1 Astellas, Inc.

2.1.1 Business Overview

2.1.2 Prostate Cancer Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Astellas, Inc. Prostate Cancer Revenue, Gross Margin and Market Share (2016-2017)

2.2 AstraZeneca plc

2.2.1 Business Overview

2.2.2 Prostate Cancer Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 AstraZeneca plc Prostate Cancer Revenue, Gross Margin and Market Share (2016-2017)

2.3 Johnson & Johnson

2.3.1 Business Overview

2.3.2 Prostate Cancer Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Johnson & Johnson Prostate Cancer Revenue, Gross Margin and Market Share (2016-2017)

2.4 Sanofi S.A

2.4.1 Business Overview

2.4.2 Prostate Cancer Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Sanofi S.A Prostate Cancer Revenue, Gross Margin and Market Share (2016-2017)

2.5 Bristol Myers Squibb (BMS)

2.5.1 Business Overview

2.5.2 Prostate Cancer Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Bristol Myers Squibb (BMS) Prostate Cancer Revenue, Gross Margin and Market Share (2016-2017)

2.6 Bayer AG

2.6.1 Business Overview

2.6.2 Prostate Cancer Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Bayer AG Prostate Cancer Revenue, Gross Margin and Market Share (2016-2017)

3 Global Prostate Cancer Market Competition, by Players

3.1 Global Prostate Cancer Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Prostate Cancer Players Market Share

3.2.2 Top 10 Prostate Cancer Players Market Share

3.3 Market Competition Trend

4 Global Prostate Cancer Market Size by Regions

4.1 Global Prostate Cancer Revenue and Market Share by Regions

4.2 North America Prostate Cancer Revenue and Growth Rate (2013-2018)

4.3 Europe Prostate Cancer Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Prostate Cancer Revenue and Growth Rate (2013-2018)

4.5 South America Prostate Cancer Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Prostate Cancer Revenue and Growth Rate (2013-2018)

5 North America Prostate Cancer Revenue by Countries

5.1 North America Prostate Cancer Revenue by Countries (2013-2018)

5.2 USA Prostate Cancer Revenue and Growth Rate (2013-2018)

5.3 Canada Prostate Cancer Revenue and Growth Rate (2013-2018)

5.4 Mexico Prostate Cancer Revenue and Growth Rate (2013-2018)

6 Europe Prostate Cancer Revenue by Countries

6.1 Europe Prostate Cancer Revenue by Countries (2013-2018)

6.2 Germany Prostate Cancer Revenue and Growth Rate (2013-2018)

6.3 UK Prostate Cancer Revenue and Growth Rate (2013-2018)

6.4 France Prostate Cancer Revenue and Growth Rate (2013-2018)

6.5 Russia Prostate Cancer Revenue and Growth Rate (2013-2018)

6.6 Italy Prostate Cancer Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Prostate Cancer Revenue by Countries

7.1 Asia-Pacific Prostate Cancer Revenue by Countries (2013-2018)

7.2 China Prostate Cancer Revenue and Growth Rate (2013-2018)

7.3 Japan Prostate Cancer Revenue and Growth Rate (2013-2018)

7.4 Korea Prostate Cancer Revenue and Growth Rate (2013-2018)

7.5 India Prostate Cancer Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Prostate Cancer Revenue and Growth Rate (2013-2018)

8 South America Prostate Cancer Revenue by Countries

8.1 South America Prostate Cancer Revenue by Countries (2013-2018)

8.2 Brazil Prostate Cancer Revenue and Growth Rate (2013-2018)

8.3 Argentina Prostate Cancer Revenue and Growth Rate (2013-2018)

8.4 Colombia Prostate Cancer Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Prostate Cancer by Countries

9.1 Middle East and Africa Prostate Cancer Revenue by Countries (2013-2018)

9.2 Saudi Arabia Prostate Cancer Revenue and Growth Rate (2013-2018)

9.3 UAE Prostate Cancer Revenue and Growth Rate (2013-2018)

9.4 Egypt Prostate Cancer Revenue and Growth Rate (2013-2018)

9.5 Nigeria Prostate Cancer Revenue and Growth Rate (2013-2018)

9.6 South Africa Prostate Cancer Revenue and Growth Rate (2013-2018)

10 Global Prostate Cancer Market Segment by Type

10.1 Global Prostate Cancer Revenue and Market Share by Type (2013-2018)

10.2 Global Prostate Cancer Market Forecast by Type (2018-2023)

10.3 Hormone sensitive prostate cancer Revenue Growth Rate (2013-2023)

10.4 Hormone refractory prostate cancer Revenue Growth Rate (2013-2023)

11 Global Prostate Cancer Market Segment by Application

11.1 Global Prostate Cancer Revenue Market Share by Application (2013-2018)

11.2 Prostate Cancer Market Forecast by Application (2018-2023)

11.3 Chemotherapy Revenue Growth (2013-2018)

11.4 Hormonal Therapy Revenue Growth (2013-2018)

11.5 Targeted Therapy Revenue Growth (2013-2018)

11.6 Immunotherapy Revenue Growth (2013-2018)

12 Global Prostate Cancer Market Size Forecast (2018-2023)

12.1 Global Prostate Cancer Market Size Forecast (2018-2023)

12.2 Global Prostate Cancer Market Forecast by Regions (2018-2023)

12.3 North America Prostate Cancer Revenue Market Forecast (2018-2023)

12.4 Europe Prostate Cancer Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Prostate Cancer Revenue Market Forecast (2018-2023)

12.6 South America Prostate Cancer Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Prostate Cancer Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source


List Of Table

List of Tables and Figures

Figure Prostate Cancer Picture

Table Product Specifications of Prostate Cancer

Table Global Prostate Cancer and Revenue (Million USD) Market Split by Product Type

Figure Global Prostate Cancer Revenue Market Share by Types in 2017

Figure Hormone sensitive prostate cancer Picture

Figure Hormone refractory prostate cancer Picture

Table Global Prostate Cancer Revenue (Million USD) by Application (2013-2023)

Figure Prostate Cancer Revenue Market Share by Applications in 2017

Figure Chemotherapy Picture

Figure Hormonal Therapy Picture

Figure Targeted Therapy Picture

Figure Immunotherapy Picture

Table Global Market Prostate Cancer Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America Prostate Cancer Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Prostate Cancer Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Prostate Cancer Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Prostate Cancer Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Prostate Cancer Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Prostate Cancer Revenue (Million USD) and Growth Rate (2013-2023)

Table Astellas, Inc. Basic Information, Manufacturing Base and Competitors

Table Astellas, Inc. Prostate Cancer Type and Applications

Table Astellas, Inc. Prostate Cancer Revenue, Gross Margin and Market Share (2016-2017)

Table AstraZeneca plc Basic Information, Manufacturing Base and Competitors

Table AstraZeneca plc Prostate Cancer Type and Applications

Table AstraZeneca plc Prostate Cancer Revenue, Gross Margin and Market Share (2016-2017)

Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors

Table Johnson & Johnson Prostate Cancer Type and Applications

Table Johnson & Johnson Prostate Cancer Revenue, Gross Margin and Market Share (2016-2017)

Table Sanofi S.A Basic Information, Manufacturing Base and Competitors

Table Sanofi S.A Prostate Cancer Type and Applications

Table Sanofi S.A Prostate Cancer Revenue, Gross Margin and Market Share (2016-2017)

Table Bristol Myers Squibb (BMS) Basic Information, Manufacturing Base and Competitors

Table Bristol Myers Squibb (BMS) Prostate Cancer Type and Applications

Table Bristol Myers Squibb (BMS) Prostate Cancer Revenue, Gross Margin and Market Share (2016-2017)

Table Bayer AG Basic Information, Manufacturing Base and Competitors

Table Bayer AG Prostate Cancer Type and Applications

Table Bayer AG Prostate Cancer Revenue, Gross Margin and Market Share (2016-2017)

Table Global Prostate Cancer Revenue (Million USD) by Players (2013-2018)

Table Global Prostate Cancer Revenue Share by Players (2013-2018)

Figure Global Prostate Cancer Revenue Share by Players in 2016

Figure Global Prostate Cancer Revenue Share by Players in 2017

Figure Global Top 5 Players Prostate Cancer Revenue Market Share in 2017

Figure Global Top 10 Players Prostate Cancer Revenue Market Share in 2017

Figure Global Prostate Cancer Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global Prostate Cancer Revenue (Million USD) by Regions (2013-2018)

Table Global Prostate Cancer Revenue Market Share by Regions (2013-2018)

Figure Global Prostate Cancer Revenue Market Share by Regions (2013-2018)

Figure Global Prostate Cancer Revenue Market Share by Regions in 2017

Figure North America Prostate Cancer Revenue and Growth Rate (2013-2018)

Figure Europe Prostate Cancer Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Prostate Cancer Revenue and Growth Rate (2013-2018)

Figure South America Prostate Cancer Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Prostate Cancer Revenue and Growth Rate (2013-2018)

Table North America Prostate Cancer Revenue by Countries (2013-2018)

Table North America Prostate Cancer Revenue Market Share by Countries (2013-2018)

Figure North America Prostate Cancer Revenue Market Share by Countries (2013-2018)

Figure North America Prostate Cancer Revenue Market Share by Countries in 2017

Figure USA Prostate Cancer Revenue and Growth Rate (2013-2018)

Figure Canada Prostate Cancer Revenue and Growth Rate (2013-2018)

Figure Mexico Prostate Cancer Revenue and Growth Rate (2013-2018)

Table Europe Prostate Cancer Revenue (Million USD) by Countries (2013-2018)

Figure Europe Prostate Cancer Revenue Market Share by Countries (2013-2018)

Figure Europe Prostate Cancer Revenue Market Share by Countries in 2017

Figure Germany Prostate Cancer Revenue and Growth Rate (2013-2018)

Figure UK Prostate Cancer Revenue and Growth Rate (2013-2018)

Figure France Prostate Cancer Revenue and Growth Rate (2013-2018)

Figure Russia Prostate Cancer Revenue and Growth Rate (2013-2018)

Figure Italy Prostate Cancer Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Prostate Cancer Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific Prostate Cancer Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific Prostate Cancer Revenue Market Share by Countries in 2017

Figure China Prostate Cancer Revenue and Growth Rate (2013-2018)

Figure Japan Prostate Cancer Revenue and Growth Rate (2013-2018)

Figure Korea Prostate Cancer Revenue and Growth Rate (2013-2018)

Figure India Prostate Cancer Revenue and Growth Rate (2013-2018)

Figure Southeast Asia Prostate Cancer Revenue and Growth Rate (2013-2018)

Table South America Prostate Cancer Revenue by Countries (2013-2018)

Table South America Prostate Cancer Revenue Market Share by Countries (2013-2018)

Figure South America Prostate Cancer Revenue Market Share by Countries (2013-2018)

Figure South America Prostate Cancer Revenue Market Share by Countries in 2017

Figure Brazil Prostate Cancer Revenue and Growth Rate (2013-2018)

Figure Argentina Prostate Cancer Revenue and Growth Rate (2013-2018)

Figure Colombia Prostate Cancer Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Prostate Cancer Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa Prostate Cancer Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Prostate Cancer Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Prostate Cancer Revenue Market Share by Countries in 2017

Figure Saudi Arabia Prostate Cancer Revenue and Growth Rate (2013-2018)

Figure UAE Prostate Cancer Revenue and Growth Rate (2013-2018)

Figure Egypt Prostate Cancer Revenue and Growth Rate (2013-2018)

Figure Nigeria Prostate Cancer Revenue and Growth Rate (2013-2018)

Figure South Africa Prostate Cancer Revenue and Growth Rate (2013-2018)

Table Global Prostate Cancer Revenue (Million USD) by Type (2013-2018)

Table Global Prostate Cancer Revenue Share by Type (2013-2018)

Figure Global Prostate Cancer Revenue Share by Type (2013-2018)

Figure Global Prostate Cancer Revenue Share by Type in 2017

Table Global Prostate Cancer Revenue Forecast by Type (2018-2023)

Figure Global Prostate Cancer Market Share Forecast by Type (2018-2023)

Figure Global Hormone sensitive prostate cancer Revenue Growth Rate (2013-2018)

Figure Global Hormone refractory prostate cancer Revenue Growth Rate (2013-2018)

Table Global Prostate Cancer Revenue by Application (2013-2018)

Table Global Prostate Cancer Revenue Share by Application (2013-2018)

Figure Global Prostate Cancer Revenue Share by Application (2013-2018)

Figure Global Prostate Cancer Revenue Share by Application in 2017

Table Global Prostate Cancer Revenue Forecast by Application (2018-2023)

Figure Global Prostate Cancer Market Share Forecast by Application (2018-2023)

Figure Global Chemotherapy Revenue Growth Rate (2013-2018)

Figure Global Hormonal Therapy Revenue Growth Rate (2013-2018)

Figure Global Targeted Therapy Revenue Growth Rate (2013-2018)

Figure Global Immunotherapy Revenue Growth Rate (2013-2018)

Figure Global Prostate Cancer Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global Prostate Cancer Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global Prostate Cancer Revenue Market Share Forecast by Regions (2018-2023)

Figure North America Prostate Cancer Revenue Market Forecast (2018-2023)

Figure Europe Prostate Cancer Revenue Market Forecast (2018-2023)

Figure Asia-Pacific Prostate Cancer Revenue Market Forecast (2018-2023)

Figure South America Prostate Cancer Revenue Market Forecast (2018-2023)

Figure Middle East and Africa Prostate Cancer Revenue Market Forecast (2018-2023)

Licence Rights

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Astellas, Inc.

AstraZeneca plc

Johnson & Johnson

Sanofi S.A

Bristol Myers Squibb (BMS)

Bayer AG

Prostate cancer is cancer that occurs in the prostate.

Scope of the Report:

This report studies the Prostate Cancer market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Prostate Cancer market by product type and applications/end industries.

The global Prostate Cancer market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Prostate Cancer.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Astellas, Inc.

AstraZeneca plc

Johnson & Johnson

Sanofi S.A

Bristol Myers Squibb (BMS)

Bayer AG

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Hormone sensitive prostate cancer

Hormone refractory prostate cancer

Market Segment by Applications, can be divided into

Chemotherapy

Hormonal Therapy

Targeted Therapy

Immunotherapy

READ MORE

Scope

Table of Contents

1 Prostate Cancer Market Overview

1.1 Product Overview and Scope of Prostate Cancer

1.2 Classification of Prostate Cancer by Types

1.2.1 Global Prostate Cancer Revenue Comparison by Types (2017-2023)

1.2.2 Global Prostate Cancer Revenue Market Share by Types in 2017

1.2.3 Hormone sensitive prostate cancer

1.2.4 Hormone refractory prostate cancer

1.3 Global Prostate Cancer Market by Application

1.3.1 Global Prostate Cancer Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Chemotherapy

1.3.3 Hormonal Therapy

1.3.4 Targeted Therapy

1.3.5 Immunotherapy

1.4 Global Prostate Cancer Market by Regions

1.4.1 Global Prostate Cancer Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Prostate Cancer Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Prostate Cancer Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Prostate Cancer Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Prostate Cancer Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Prostate Cancer Status and Prospect (2013-2023)

1.5 Global Market Size of Prostate Cancer (2013-2023)

2 Manufacturers Profiles

2.1 Astellas, Inc.

2.1.1 Business Overview

2.1.2 Prostate Cancer Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Astellas, Inc. Prostate Cancer Revenue, Gross Margin and Market Share (2016-2017)

2.2 AstraZeneca plc

2.2.1 Business Overview

2.2.2 Prostate Cancer Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 AstraZeneca plc Prostate Cancer Revenue, Gross Margin and Market Share (2016-2017)

2.3 Johnson & Johnson

2.3.1 Business Overview

2.3.2 Prostate Cancer Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Johnson & Johnson Prostate Cancer Revenue, Gross Margin and Market Share (2016-2017)

2.4 Sanofi S.A

2.4.1 Business Overview

2.4.2 Prostate Cancer Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Sanofi S.A Prostate Cancer Revenue, Gross Margin and Market Share (2016-2017)

2.5 Bristol Myers Squibb (BMS)

2.5.1 Business Overview

2.5.2 Prostate Cancer Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Bristol Myers Squibb (BMS) Prostate Cancer Revenue, Gross Margin and Market Share (2016-2017)

2.6 Bayer AG

2.6.1 Business Overview

2.6.2 Prostate Cancer Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Bayer AG Prostate Cancer Revenue, Gross Margin and Market Share (2016-2017)

3 Global Prostate Cancer Market Competition, by Players

3.1 Global Prostate Cancer Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Prostate Cancer Players Market Share

3.2.2 Top 10 Prostate Cancer Players Market Share

3.3 Market Competition Trend

4 Global Prostate Cancer Market Size by Regions

4.1 Global Prostate Cancer Revenue and Market Share by Regions

4.2 North America Prostate Cancer Revenue and Growth Rate (2013-2018)

4.3 Europe Prostate Cancer Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Prostate Cancer Revenue and Growth Rate (2013-2018)

4.5 South America Prostate Cancer Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Prostate Cancer Revenue and Growth Rate (2013-2018)

5 North America Prostate Cancer Revenue by Countries

5.1 North America Prostate Cancer Revenue by Countries (2013-2018)

5.2 USA Prostate Cancer Revenue and Growth Rate (2013-2018)

5.3 Canada Prostate Cancer Revenue and Growth Rate (2013-2018)

5.4 Mexico Prostate Cancer Revenue and Growth Rate (2013-2018)

6 Europe Prostate Cancer Revenue by Countries

6.1 Europe Prostate Cancer Revenue by Countries (2013-2018)

6.2 Germany Prostate Cancer Revenue and Growth Rate (2013-2018)

6.3 UK Prostate Cancer Revenue and Growth Rate (2013-2018)

6.4 France Prostate Cancer Revenue and Growth Rate (2013-2018)

6.5 Russia Prostate Cancer Revenue and Growth Rate (2013-2018)

6.6 Italy Prostate Cancer Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Prostate Cancer Revenue by Countries

7.1 Asia-Pacific Prostate Cancer Revenue by Countries (2013-2018)

7.2 China Prostate Cancer Revenue and Growth Rate (2013-2018)

7.3 Japan Prostate Cancer Revenue and Growth Rate (2013-2018)

7.4 Korea Prostate Cancer Revenue and Growth Rate (2013-2018)

7.5 India Prostate Cancer Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Prostate Cancer Revenue and Growth Rate (2013-2018)

8 South America Prostate Cancer Revenue by Countries

8.1 South America Prostate Cancer Revenue by Countries (2013-2018)

8.2 Brazil Prostate Cancer Revenue and Growth Rate (2013-2018)

8.3 Argentina Prostate Cancer Revenue and Growth Rate (2013-2018)

8.4 Colombia Prostate Cancer Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Prostate Cancer by Countries

9.1 Middle East and Africa Prostate Cancer Revenue by Countries (2013-2018)

9.2 Saudi Arabia Prostate Cancer Revenue and Growth Rate (2013-2018)

9.3 UAE Prostate Cancer Revenue and Growth Rate (2013-2018)

9.4 Egypt Prostate Cancer Revenue and Growth Rate (2013-2018)

9.5 Nigeria Prostate Cancer Revenue and Growth Rate (2013-2018)

9.6 South Africa Prostate Cancer Revenue and Growth Rate (2013-2018)

10 Global Prostate Cancer Market Segment by Type

10.1 Global Prostate Cancer Revenue and Market Share by Type (2013-2018)

10.2 Global Prostate Cancer Market Forecast by Type (2018-2023)

10.3 Hormone sensitive prostate cancer Revenue Growth Rate (2013-2023)

10.4 Hormone refractory prostate cancer Revenue Growth Rate (2013-2023)

11 Global Prostate Cancer Market Segment by Application

11.1 Global Prostate Cancer Revenue Market Share by Application (2013-2018)

11.2 Prostate Cancer Market Forecast by Application (2018-2023)

11.3 Chemotherapy Revenue Growth (2013-2018)

11.4 Hormonal Therapy Revenue Growth (2013-2018)

11.5 Targeted Therapy Revenue Growth (2013-2018)

11.6 Immunotherapy Revenue Growth (2013-2018)

12 Global Prostate Cancer Market Size Forecast (2018-2023)

12.1 Global Prostate Cancer Market Size Forecast (2018-2023)

12.2 Global Prostate Cancer Market Forecast by Regions (2018-2023)

12.3 North America Prostate Cancer Revenue Market Forecast (2018-2023)

12.4 Europe Prostate Cancer Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Prostate Cancer Revenue Market Forecast (2018-2023)

12.6 South America Prostate Cancer Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Prostate Cancer Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source


List Of Table

List of Tables and Figures

Figure Prostate Cancer Picture

Table Product Specifications of Prostate Cancer

Table Global Prostate Cancer and Revenue (Million USD) Market Split by Product Type

Figure Global Prostate Cancer Revenue Market Share by Types in 2017

Figure Hormone sensitive prostate cancer Picture

Figure Hormone refractory prostate cancer Picture

Table Global Prostate Cancer Revenue (Million USD) by Application (2013-2023)

Figure Prostate Cancer Revenue Market Share by Applications in 2017

Figure Chemotherapy Picture

Figure Hormonal Therapy Picture

Figure Targeted Therapy Picture

Figure Immunotherapy Picture

Table Global Market Prostate Cancer Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America Prostate Cancer Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Prostate Cancer Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Prostate Cancer Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Prostate Cancer Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Prostate Cancer Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Prostate Cancer Revenue (Million USD) and Growth Rate (2013-2023)

Table Astellas, Inc. Basic Information, Manufacturing Base and Competitors

Table Astellas, Inc. Prostate Cancer Type and Applications

Table Astellas, Inc. Prostate Cancer Revenue, Gross Margin and Market Share (2016-2017)

Table AstraZeneca plc Basic Information, Manufacturing Base and Competitors

Table AstraZeneca plc Prostate Cancer Type and Applications

Table AstraZeneca plc Prostate Cancer Revenue, Gross Margin and Market Share (2016-2017)

Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors

Table Johnson & Johnson Prostate Cancer Type and Applications

Table Johnson & Johnson Prostate Cancer Revenue, Gross Margin and Market Share (2016-2017)

Table Sanofi S.A Basic Information, Manufacturing Base and Competitors

Table Sanofi S.A Prostate Cancer Type and Applications

Table Sanofi S.A Prostate Cancer Revenue, Gross Margin and Market Share (2016-2017)

Table Bristol Myers Squibb (BMS) Basic Information, Manufacturing Base and Competitors

Table Bristol Myers Squibb (BMS) Prostate Cancer Type and Applications

Table Bristol Myers Squibb (BMS) Prostate Cancer Revenue, Gross Margin and Market Share (2016-2017)

Table Bayer AG Basic Information, Manufacturing Base and Competitors

Table Bayer AG Prostate Cancer Type and Applications

Table Bayer AG Prostate Cancer Revenue, Gross Margin and Market Share (2016-2017)

Table Global Prostate Cancer Revenue (Million USD) by Players (2013-2018)

Table Global Prostate Cancer Revenue Share by Players (2013-2018)

Figure Global Prostate Cancer Revenue Share by Players in 2016

Figure Global Prostate Cancer Revenue Share by Players in 2017

Figure Global Top 5 Players Prostate Cancer Revenue Market Share in 2017

Figure Global Top 10 Players Prostate Cancer Revenue Market Share in 2017

Figure Global Prostate Cancer Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global Prostate Cancer Revenue (Million USD) by Regions (2013-2018)

Table Global Prostate Cancer Revenue Market Share by Regions (2013-2018)

Figure Global Prostate Cancer Revenue Market Share by Regions (2013-2018)

Figure Global Prostate Cancer Revenue Market Share by Regions in 2017

Figure North America Prostate Cancer Revenue and Growth Rate (2013-2018)

Figure Europe Prostate Cancer Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Prostate Cancer Revenue and Growth Rate (2013-2018)

Figure South America Prostate Cancer Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Prostate Cancer Revenue and Growth Rate (2013-2018)

Table North America Prostate Cancer Revenue by Countries (2013-2018)

Table North America Prostate Cancer Revenue Market Share by Countries (2013-2018)

Figure North America Prostate Cancer Revenue Market Share by Countries (2013-2018)

Figure North America Prostate Cancer Revenue Market Share by Countries in 2017

Figure USA Prostate Cancer Revenue and Growth Rate (2013-2018)

Figure Canada Prostate Cancer Revenue and Growth Rate (2013-2018)

Figure Mexico Prostate Cancer Revenue and Growth Rate (2013-2018)

Table Europe Prostate Cancer Revenue (Million USD) by Countries (2013-2018)

Figure Europe Prostate Cancer Revenue Market Share by Countries (2013-2018)

Figure Europe Prostate Cancer Revenue Market Share by Countries in 2017

Figure Germany Prostate Cancer Revenue and Growth Rate (2013-2018)

Figure UK Prostate Cancer Revenue and Growth Rate (2013-2018)

Figure France Prostate Cancer Revenue and Growth Rate (2013-2018)

Figure Russia Prostate Cancer Revenue and Growth Rate (2013-2018)

Figure Italy Prostate Cancer Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Prostate Cancer Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific Prostate Cancer Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific Prostate Cancer Revenue Market Share by Countries in 2017

Figure China Prostate Cancer Revenue and Growth Rate (2013-2018)

Figure Japan Prostate Cancer Revenue and Growth Rate (2013-2018)

Figure Korea Prostate Cancer Revenue and Growth Rate (2013-2018)

Figure India Prostate Cancer Revenue and Growth Rate (2013-2018)

Figure Southeast Asia Prostate Cancer Revenue and Growth Rate (2013-2018)

Table South America Prostate Cancer Revenue by Countries (2013-2018)

Table South America Prostate Cancer Revenue Market Share by Countries (2013-2018)

Figure South America Prostate Cancer Revenue Market Share by Countries (2013-2018)

Figure South America Prostate Cancer Revenue Market Share by Countries in 2017

Figure Brazil Prostate Cancer Revenue and Growth Rate (2013-2018)

Figure Argentina Prostate Cancer Revenue and Growth Rate (2013-2018)

Figure Colombia Prostate Cancer Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Prostate Cancer Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa Prostate Cancer Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Prostate Cancer Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Prostate Cancer Revenue Market Share by Countries in 2017

Figure Saudi Arabia Prostate Cancer Revenue and Growth Rate (2013-2018)

Figure UAE Prostate Cancer Revenue and Growth Rate (2013-2018)

Figure Egypt Prostate Cancer Revenue and Growth Rate (2013-2018)

Figure Nigeria Prostate Cancer Revenue and Growth Rate (2013-2018)

Figure South Africa Prostate Cancer Revenue and Growth Rate (2013-2018)

Table Global Prostate Cancer Revenue (Million USD) by Type (2013-2018)

Table Global Prostate Cancer Revenue Share by Type (2013-2018)

Figure Global Prostate Cancer Revenue Share by Type (2013-2018)

Figure Global Prostate Cancer Revenue Share by Type in 2017

Table Global Prostate Cancer Revenue Forecast by Type (2018-2023)

Figure Global Prostate Cancer Market Share Forecast by Type (2018-2023)

Figure Global Hormone sensitive prostate cancer Revenue Growth Rate (2013-2018)

Figure Global Hormone refractory prostate cancer Revenue Growth Rate (2013-2018)

Table Global Prostate Cancer Revenue by Application (2013-2018)

Table Global Prostate Cancer Revenue Share by Application (2013-2018)

Figure Global Prostate Cancer Revenue Share by Application (2013-2018)

Figure Global Prostate Cancer Revenue Share by Application in 2017

Table Global Prostate Cancer Revenue Forecast by Application (2018-2023)

Figure Global Prostate Cancer Market Share Forecast by Application (2018-2023)

Figure Global Chemotherapy Revenue Growth Rate (2013-2018)

Figure Global Hormonal Therapy Revenue Growth Rate (2013-2018)

Figure Global Targeted Therapy Revenue Growth Rate (2013-2018)

Figure Global Immunotherapy Revenue Growth Rate (2013-2018)

Figure Global Prostate Cancer Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global Prostate Cancer Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global Prostate Cancer Revenue Market Share Forecast by Regions (2018-2023)

Figure North America Prostate Cancer Revenue Market Forecast (2018-2023)

Figure Europe Prostate Cancer Revenue Market Forecast (2018-2023)

Figure Asia-Pacific Prostate Cancer Revenue Market Forecast (2018-2023)

Figure South America Prostate Cancer Revenue Market Forecast (2018-2023)

Figure Middle East and Africa Prostate Cancer Revenue Market Forecast (2018-2023)

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Companies

Astellas, Inc.

AstraZeneca plc

Johnson & Johnson

Sanofi S.A

Bristol Myers Squibb (BMS)

Bayer AG